Contemporary analysis of ETEST for antibiotic susceptibility and minimum inhibitory concentration agreement against Pseudomonas aeruginosa from patients with cystic fibrosis

被引：0
|
作者：
Maxwell J. Lasko
Holly K. Huse
David P. Nicolau
Joseph L. Kuti
机构：
[1] Hartford Hospital,Center for Anti
[2] Huntington Hospital,Infective Research and Development
[3] Hartford Hospital,Department of Clinical Microbiology
[4] Harbor-UCLA Medical Center,Division of Infectious Diseases
来源：
Annals of Clinical Microbiology and Antimicrobials | / 20卷
关键词：
Antibiotic resistance; Broth microdilution; Ceftazidime–avibactam; Ceftolozane–tazobactam;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Antibiotic tolerance induced by lactoferrin in clinical Pseudomonas aeruginosa isolates from cystic fibrosis patients
    Andrés, MT
    Viejo-Diaz, M
    Pérez, F
    Fierro, JF
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2005, 49 (04) : 1613 - 1616
  • [32] Antibodies against Pseudomonas aeruginosa in patients with cystic fibrosis - clinical application
    Petrova, Guergana
    Perenovska, Penka
    Lesichkova, Spaska
    Lazova, Snezhina
    Miteva, Dimitrinka
    Cholakova, Kristina
    Strateva, Tanya
    EUROPEAN RESPIRATORY JOURNAL, 2018, 52
  • [33] Early eradication therapy against Pseudomonas aeruginosa in cystic fibrosis patients
    Taccetti, G
    Campana, S
    Festini, F
    Mascherini, M
    Döring, G
    EUROPEAN RESPIRATORY JOURNAL, 2005, 26 (03) : 458 - 461
  • [34] MIXED MORPHOTYPE SUSCEPTIBILITY TESTING OF PSEUDOMONAS-AERUGINOSA FROM PATIENTS WITH CYSTIC-FIBROSIS
    DUNNE, WM
    CHUSID, MJ
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1987, 6 (02) : 165 - 170
  • [35] Pitfalls of polymyxin antimicrobial susceptibility testing of Pseudomonas aeruginosa isolated from cystic fibrosis patients
    Hogardt, M
    Schmoldt, S
    Götzfried, M
    Adler, K
    Heesemann, J
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2004, 54 (06) : 1057 - 1061
  • [36] Molecular analysis of Pseudomonas aeruginosa strains isolated from cystic fibrosis patients
    Dariusz Jarych
    Ewa Augustynowicz-Kopec
    Agnieszka Iwanska
    Pawel Parniewski
    Marta Majchrzak
    Scientific Reports, 11
  • [37] PSEUDOMONAS-AERUGINOSA FROM CYSTIC-FIBROSIS PATIENTS - SUSCEPTIBILITY TESTING OF ORAL ISOLATES
    KAUFMAN, AK
    LINDEMANN, RA
    NEWMAN, MG
    LE, TV
    JOURNAL OF DENTAL RESEARCH, 1984, 63 : 186 - 186
  • [38] Susceptibility of Pseudomonas aeruginosa Recovered from Cystic Fibrosis Patients to Murepavadin and 13 Comparator Antibiotics
    Ekkelenkamp, Miquel B.
    Canton, Rafael
    Diez-Aguilar, Maria
    Tunney, Michael M.
    Gilpin, Deirdre F.
    Bernardini, Francesca
    Dale, Glenn E.
    Elborn, J. Stuart
    Bayjanov, Jumamurat R.
    Fluit, Ad
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2020, 64 (02)
  • [39] Clinically feasible biofilm susceptibility assay for isolates of Pseudomonas aeruginosa from patients with cystic fibrosis
    Moskowitz, SM
    Foster, JM
    Emerson, J
    Burns, JL
    JOURNAL OF CLINICAL MICROBIOLOGY, 2004, 42 (05) : 1915 - 1922
  • [40] Molecular analysis of Pseudomonas aeruginosa strains isolated from cystic fibrosis patients
    Jarych, Dariusz
    Augustynowicz-Kopec, Ewa
    Iwanska, Agnieszka
    Parniewski, Pawel
    Majchrzak, Marta
    SCIENTIFIC REPORTS, 2021, 11 (01)
12345